Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...

The study underscores the advantages of small molecule ICIs over traditional antibody-based therapies. These small-molecule drugs exhibit superior tissue permeability, better oral bioavailability ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Using an innovative antibody fragment technique as a drug screening tool, the lab has identified a range of potent anti-cancer compounds targeted against both proteins. Some of these compounds are ...

67 WALL STREET, New York - May 3, 2013 - The Wall Street Transcript has just published its Biotechnology and Pharmaceuticals Report offering a timely review of the sector to serious investors and ...

DelveInsight’s, “ Idiopathic Pulmonary Fibrosis Pipeline Insights 2025 ” report provides comprehensive insights about 80+ ...

“We have identified a small molecule that binds to the virus’s surface protein and prevents infection. This molecule, known as E10, belongs to a class of so-called nanobodies.

A first encounter with the dengue virus typically causes very mild symptoms; however, a subsequent infection is a different story. For a small proportion of people who are re-infected, the virus can ...

Lead inventors Professor Terence Rabbits’ laboratory focuses on developing technologies using intracellular antibody fragments and small molecule derivatives, mainly aimed at targeting chromosomal ...

Researchers at the University of Gothenburg, Sweden, in collaboration with colleagues in China, have discovered an antibody-like molecule that can protect mice from various influenza viruses. The ...